Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(7 Publications)
Rabbit Recombinant Monoclonal RNF185 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
E3 ubiquitin-protein ligase RNF185, RING finger protein 185, RNF185
- IP
Supplier Data
Immunoprecipitation - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (AB181999)
Western blot analysis of immunoprecipitation pellet from HeLa cell lysate immunoprecipitated using ab181999 at 1/40 dilution (lane 1) or a negative control (lane 2) followed by Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.
All lanes:
Immunoprecipitation - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (ab181999)
false
- WB
Supplier Data
Western blot - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (AB181999)
All lanes:
Western blot - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (ab181999) at 1/5000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
Human fetal brain lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L)-HRP at 1/1000 dilution
false
- WB
Lab
Western blot - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (AB181999)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] (ab181999) at 1/10000 dilution
Lane 1:
Human RNF185 full-length ORF recombinant protein with GST-tag at N-terminal at 10 µg
Lane 2:
Human RNF5 full-length ORF recombinant protein with GST-tag at N-terminal at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 1s
Related conjugates and formulations (1)
-
Anti-RNF185 + RNF5/NG2 antibody [EPR14070-94] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RNF185 regulates protein homeostasis by marking target proteins for degradation via ubiquitination. It does not act alone; often it forms part of a larger complex that includes components like E2 ubiquitin-conjugating enzymes. This activity ensures that cells maintain the proper levels of proteins helping remove misfolded or damaged proteins. The complex activity of RNF185 is essential for cellular quality control mechanisms maintaining balance within the protein environment of the cell.
Pathways
Involvement of RNF185 connects it to important cellular processes including the endoplasmic reticulum-associated degradation (ERAD) pathway and the Wnt signaling pathway. In ERAD RNF185 collaborates with other proteins such as RNF5 to facilitate degradation of misfolded proteins in the endoplasmic reticulum. Through the Wnt pathway control of protein levels by RNF185 influences cellular proliferation and differentiation processes that are essential for proper tissue development and homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Journal of pharmaceutical analysis 14:335-347 PubMed38618242
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nutrition & metabolism 21:5 PubMed38167476
2024
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 20:1286-1313 PubMed38084826
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111675 PubMed36417855
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 82:4277-4289.e10 PubMed36283413
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 23:e54859 PubMed35979733
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 79:768-781.e7 PubMed32738194
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com